Nomura Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.8M | Buy |
91,374
+4,531
| +5% | +$1.48M | 0.08% | 257 |
|
|
2025
Q1 | $23.4M | Buy |
86,843
+4,058
| +5% | +$1.1M | 0.07% | 265 |
|
|
2024
Q4 | $19.5M | Sell |
82,785
-2,660
| -3% | -$626K | 0.06% | 286 |
|
|
2024
Q3 | $23.5M | Buy |
85,445
+6,148
| +8% | +$1.69M | 0.07% | 249 |
|
|
2024
Q2 | $19.3M | Sell |
79,297
-446
| -0.6% | -$108K | 0.07% | 257 |
|
|
2024
Q1 | $11.9M | Buy |
79,743
+10,732
| +16% | +$1.6M | 0.04% | 345 |
|
|
2023
Q4 | $13.2M | Buy |
69,011
+994
| +1% | +$190K | 0.05% | 314 |
|
|
2023
Q3 | $12M | Buy |
68,017
+1,804
| +3% | +$319K | 0.06% | 307 |
|
|
2023
Q2 | $12.6M | Sell |
66,213
-1,085
| -2% | -$206K | 0.06% | 301 |
|
|
2023
Q1 | $13.5M | Buy |
67,298
+9,798
| +17% | +$1.96M | 0.07% | 278 |
|
|
2022
Q4 | $13.7M | Sell |
57,500
-1,308
| -2% | -$311K | 0.08% | 269 |
|
|
2022
Q3 | $11.8M | Sell |
58,808
-2,176
| -4% | -$436K | 0.07% | 279 |
|
|
2022
Q2 | $8.89M | Sell |
60,984
-1,926
| -3% | -$281K | 0.06% | 323 |
|
|
2022
Q1 | $10.3M | Sell |
62,910
-617
| -1% | -$101K | 0.06% | 328 |
|
|
2021
Q4 | $10.8M | Buy |
63,527
+20,703
| +48% | +$3.51M | 0.05% | 316 |
|
|
2021
Q3 | $8.09M | Buy |
42,824
+1,015
| +2% | +$192K | 0.05% | 351 |
|
|
2021
Q2 | $7.09M | Buy |
41,809
+1,195
| +3% | +$203K | 0.04% | 390 |
|
|
2021
Q1 | $5.73M | Buy |
40,614
+20,099
| +98% | +$2.84M | 0.04% | 420 |
|
|
2020
Q4 | $2.67M | Buy |
20,515
+1,420
| +7% | +$185K | 0.02% | 605 |
|
|
2020
Q3 | $2.78M | Hold |
19,095
| – | – | 0.02% | 512 |
|
|
2020
Q2 | $2.83M | Buy |
19,095
+505
| +3% | +$74.8K | 0.02% | 482 |
|
|
2020
Q1 | $2.02M | Buy |
18,590
+1,000
| +6% | +$109K | 0.02% | 504 |
|
|
2019
Q4 | $2.03M | Sell |
17,590
-510
| -3% | -$58.7K | 0.02% | 616 |
|
|
2019
Q3 | $1.46M | Buy |
18,100
+4,560
| +34% | +$367K | 0.01% | 681 |
|
|
2019
Q2 | $982K | Hold |
13,540
| – | – | 0.01% | 781 |
|
|
2019
Q1 | $1.27M | Hold |
13,540
| – | – | 0.01% | 703 |
|
|
2018
Q4 | $987K | Buy |
13,540
+1,600
| +13% | +$117K | 0.01% | 702 |
|
|
2018
Q3 | $1.05M | Hold |
11,940
| – | – | 0.01% | 728 |
|
|
2018
Q2 | $1.18M | Buy |
11,940
+1,200
| +11% | +$118K | 0.01% | 700 |
|
|
2018
Q1 | $1.28M | Hold |
10,740
| – | – | 0.01% | 662 |
|
|
2017
Q4 | $1.37M | Buy |
+10,740
| New | +$1.37M | 0.02% | 641 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 924 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 946 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 974 |
|
|
2016
Q4 | – | Sell |
-8,000
| Closed | -$542K | – | 1441 |
|
|
2016
Q3 | $542K | Hold |
8,000
| – | – | 0.01% | 798 |
|
|
2016
Q2 | $444K | Hold |
8,000
| – | – | 0.01% | 813 |
|
|
2016
Q1 | $502K | Buy |
8,000
+500
| +7% | +$31.4K | 0.01% | 791 |
|
|
2015
Q4 | $706K | Hold |
7,500
| – | – | 0.01% | 721 |
|
|
2015
Q3 | $603K | Buy |
7,500
+200
| +3% | +$16.1K | 0.01% | 760 |
|
|
2015
Q2 | $875K | Buy |
+7,300
| New | +$875K | 0.02% | 653 |
|